New study aims to end asthma vs. COPD confusion with High-Tech imaging
NCT ID NCT07602192
First seen Jun 25, 2026 · Last updated Jul 08, 2026 · Updated 3 times
Summary
This study is enrolling 200 adults with asthma or COPD to see if combining chest CT scans with blood, sputum, and microbiome tests can more accurately tell the two diseases apart. Researchers will also look for clues that predict how well a patient will respond to treatment. No experimental drugs are involved—the goal is to improve diagnosis and personalize care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a more accurate way to diagnose asthma versus COPD and help doctors choose the right treatment for each patient.
- What could go wrong
- This is an observational study, not a treatment trial. The results may not lead to immediate changes in care, and the findings might not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Korea University Guro Hospital
RECRUITINGSeoul, Guro-gu, 08308, South Korea
-
SMG-SNU Boramae Medical Center
RECRUITINGSeoul, Dongjak-gu, 07061, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple symptom check replace a grueling exercise test for kids?
- Smart breathing machines at home: a new way to predict COPD crises?
- Can tracking severe asthma over time unlock better treatments?
- Can ancient cupping ease asthma?
- Could remote rehab keep COPD patients out of the hospital?
- Breathing easy? new X-Ray method may spot COPD decline early